Rocket Pharmaceuticals
RCKT
RCKT
78 hedge funds and large institutions have $206M invested in Rocket Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
89% less call options, than puts
Call options by funds: $447K | Put options by funds: $4.08M
Holders
78
Holding in Top 10
2
Calls
$447K
Puts
$4.08M
Top Buyers
| 1 | +$4.34M | |
| 2 | +$2.25M | |
| 3 | +$2.08M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$1.61M |
Top Sellers
| 1 | -$526K | |
| 2 | -$424K | |
| 3 | -$317K | |
| 4 |
SAM
Senzar Asset Management
New York
|
-$298K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$234K |